Karen Rohan insider trades: CVS HEALTH (CVS) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Karen reports to the SEC
and 1 more company
Open-market buys and sales
17 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| May 3, 2023 | CVS | ↑ Buy | 14,000 | $69.75 | $977K | Direct | May 5, 2023 (2d) |
| Nov 18, 2019 | CVS | ↓ Sell | 80,143 | $75.00 | $6.0M | Direct | Nov 20, 2019 (2d) |
| Sep 18, 2017 | AET | ↓ Sell | 15,271 | $161.91 | $2.5M | Direct | Sep 20, 2017 (2d) |
| Jun 7, 2017 | AET | ↓ Sell | 7,825 | $149.72 | $1.2M | Direct | Jun 9, 2017 (2d) |
| Nov 11, 2016 | AET | ↓ Sell | 45,000 | $119.55 | $5.4M | Direct | Nov 15, 2016 (4d) |
| Feb 6, 2013 | AET | ↑ Buy | 4,035 | $49.53 | $200K | Direct | Feb 7, 2013 (1d) |
| Sep 2, 2011 | MGLN | ↓ Sell | 18,689 | $47.51 | $888K | Direct | Sep 7, 2011 (5d) |
| Sep 2, 2011 | MGLN | ↓ Sell | 1,411 | $47.75 | $67K | Direct | Sep 7, 2011 (5d) |
| Sep 1, 2011 | MGLN | ↓ Sell | 10,300 | $49.27 | $508K | Direct | Sep 2, 2011 (1d) |
| Sep 1, 2011 | MGLN | ↓ Sell | 1,600 | $50.17 | $80K | Direct | Sep 2, 2011 (1d) |
| Apr 27, 2011 | MGLN | ↓ Sell | 16,500 | $50.25 | $829K | Direct | Apr 28, 2011 (1d) |
| Apr 8, 2011 | MGLN | ↓ Sell | 500 | $50.01 | $25K | Direct | Apr 11, 2011 (3d) |
| Apr 8, 2011 | MGLN | ↓ Sell | 500 | $50.01 | $25K | Direct | Apr 11, 2011 (3d) |
| Nov 10, 2010 | MGLN | ↓ Sell | 17,500 | $48.98 | $857K | Direct | Nov 12, 2010 (2d) |
| Nov 9, 2010 | MGLN | ↓ Sell | 5,000 | $48.70 | $244K | Direct | Nov 10, 2010 (1d) |
| Nov 8, 2010 | MGLN | ↓ Sell | 7,500 | $48.99 | $367K | Direct | Nov 10, 2010 (2d) |
| Jun 1, 2007 | CI | ↓ Sell | 4,771 | $168.27 | $803K | Direct | Jun 4, 2007 (3d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other CVS insiders
Open-market trades in the last 12 months
About Karen Rohan's insider trades
Karen Rohan is President and CEO at CVS HEALTH (CVS). Since Jun 1, 2007, Karen has reported 2 open-market purchases worth $1.2M and 15 sales worth $19.7M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (55 filings), shares withheld for taxes (30 filings), option exercises (23 filings), shares returned to the company (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CVS insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.